Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Datema, M R; van Ree, R; Asero, R; Barreales, L; Belohlavkova, S; de Blay, F; Clausen, M; Dubakiene, R; Fernández-Perez, C; Fritsche, P; Gislason, D; Hoffmann-Sommergruber, K; Jedrzejczak-Czechowicz, M; Jongejan, L; Knulst, A C; Kowalski, M; Kralimarkova, T Z; Le, T-M; Lidholm, J; Papadopoulos, N G; Popov, T A; del Prado, N; Purohit, A; Reig, I; Seneviratne, S L; Sinaniotis, A; Versteeg, S A; Vieths, S; Zwinderman, A H; Mills, E N C; et al (2018). Component-resolved diagnosis and beyond: multivariable regression models to predict severity of hazelnut allergy. Allergy, 73(3):549-559.

Blanc, F; Bernard, H; Ah-Leung, S; Przybylski-Nicaise, L; Skov, P Stahl; Purohit, A; de Blay, F; Ballmer-Weber, B; Fritsche, P; Rivas, M Fernandez; Reig, I; Sinaniotis, A; Vassilopoulou, E; Hoffmann-Sommergruber, K; Vieths, S; Rigby, N; Mills, C; Adel-Patient, K (2015). Further studies on the biological activity of hazelnut allergens. Clinical and Translational Allergy, 5:26.

Cochrane, S A; Salt, L J; Wantling, E; Rogers, A; Coutts, J; Ballmer-Weber, B K; Fritsche, P; Fernández-Rivas, M; Reig, I; Knulst, A; Le, T-M; Asero, R; Beyer, K; Golding, M; Crevel, R; Clare Mills, E N; Mackie, A R (2012). Development of a standardized low-dose double-blind placebo-controlled challenge vehicle for the EuroPrevall project. Allergy, 67(1):107-113.

Navarini, A A; Feldmeyer, L; Töndury, B; Fritsche, P; Kamarashev, J; French, L E; Braun, R P (2011). The yellow clod sign. Archives of Dermatology, 147(11):1350.

Le, T M; Fritsche, P; Bublin, M; Oberhuber, C; Bulley, S; van Hoffen, E; Ballmer-Weber, B K; Knulst, A C; Hoffmann-Sommergruber, K (2011). Differences in the allergenicity of 6 different kiwifruit cultivars analyzed by prick-to-prick testing, open food challenges, and ELISA. Journal of Allergy and Clinical Immunology, 127(3):677-679.

Navarini, A A; Muster, M A; Kolios, A G A; Fritsche, P; Glatz, M; French, L E; Trüeb, R M (2011). Weight-based adaptation of TNF-antagonist induction versus maintenance dose. Case Reports in Dermatology, 3(2):124-129.

Bauermeister, K; Ballmer-Weber, B K; Bublin, M; Fritsche, P; Hanschmann, K M O; Hoffmann-Sommergruber, K; Lidholm, J; Oberhuber, C; Randow, S; Holzhauser, T; Vieths, S (2009). Assessment of component-resolved in vitro diagnosis of celeriac allergy. Journal of Allergy and Clinical Immunology, 124(6):1273-1281.e2.

This list was generated on Mon Sep 23 17:47:34 2019 CEST.